Hsp90 middle domain phosphorylation initiates a complex conformational program to recruit the ATPase-stimulating cochaperone Aha1.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
12 06 2019
Historique:
received: 24 10 2018
accepted: 09 05 2019
entrez: 14 6 2019
pubmed: 14 6 2019
medline: 6 7 2019
Statut: epublish

Résumé

Complex conformational dynamics are essential for function of the dimeric molecular chaperone heat shock protein 90 (Hsp90), including transient, ATP-biased N-domain dimerization that is necessary to attain ATPase competence. The intrinsic, but weak, ATP hydrolyzing activity of human Hsp90 is markedly enhanced by the co-chaperone Aha1. However, the cellular concentration of Aha1 is substoichiometric relative to Hsp90. Here we report that initial recruitment of this cochaperone to Hsp90 is markedly enhanced by phosphorylation of a highly conserved tyrosine (Y313 in Hsp90α) in the Hsp90 middle domain. Importantly, phosphomimetic mutation of Y313 promotes formation of a transient complex in which both N- and C-domains of Aha1 bind to distinct surfaces of the middle domains of opposing Hsp90 protomers prior to ATP-directed N-domain dimerization. Thus, Y313 represents a phosphorylation-sensitive conformational switch, engaged early after client loading, that affects both local and long-range conformational dynamics to facilitate initial recruitment of Aha1 to Hsp90.

Identifiants

pubmed: 31189925
doi: 10.1038/s41467-019-10463-y
pii: 10.1038/s41467-019-10463-y
pmc: PMC6561935
doi:

Substances chimiques

AHSA1 protein, human 0
HSP90 Heat-Shock Proteins 0
HSP90AA1 protein, human 0
Molecular Chaperones 0
Glutamic Acid 3KX376GY7L
Tyrosine 42HK56048U
Adenosine Triphosphatases EC 3.6.1.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2574

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM086688
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM115854
Pays : United States

Références

Sci Rep. 2018 May 2;8(1):6899
pubmed: 29720613
Mol Cell. 2010 Feb 12;37(3):344-54
pubmed: 20159554
J Biol Chem. 2006 May 19;281(20):14457-64
pubmed: 16565516
J Biol Chem. 2002 Nov 29;277(48):45942-8
pubmed: 12324468
Mol Cell Biol. 2006 Nov;26(22):8385-95
pubmed: 16982694
J Biol Chem. 1997 Mar 21;272(12):8007-12
pubmed: 9065472
J Biol Chem. 2006 Jun 16;281(24):16493-501
pubmed: 16613854
Mol Cell. 2014 Jan 23;53(2):317-29
pubmed: 24462205
EMBO J. 2004 Feb 11;23(3):511-9
pubmed: 14739935
Mol Biol Cell. 2010 Mar 15;21(6):871-84
pubmed: 20089831
J Biol Chem. 1999 Jun 18;274(25):17525-33
pubmed: 10364185
J Cell Biol. 1998 Nov 16;143(4):901-10
pubmed: 9817749
Proteomics. 2013 Jan;13(1):22-4
pubmed: 23148064
Mol Cell. 2012 Feb 24;45(4):517-28
pubmed: 22365831
J Vis Exp. 2013 Nov 29;(81):
pubmed: 24326301
Nat Chem Biol. 2016 Aug;12(8):628-35
pubmed: 27322067
Biophys J. 2017 Oct 17;113(8):1711-1718
pubmed: 29045865
Mol Endocrinol. 1998 Mar;12(3):342-54
pubmed: 9514152
Biochem Mol Biol J. 2017 Jan 30;3(1):2
pubmed: 28289734
Mol Cell. 2012 Aug 10;47(3):434-43
pubmed: 22727666
Biochim Biophys Acta. 2012 Mar;1823(3):648-55
pubmed: 21856339
Cell Chem Biol. 2016 Jun 23;23(6):716-26
pubmed: 27341434
Nat Struct Mol Biol. 2016 Nov;23(11):1020-1028
pubmed: 27723736
Adv Cancer Res. 2016;129:31-50
pubmed: 26916000
Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):580-5
pubmed: 21183720
Nat Commun. 2018 Jan 17;9(1):265
pubmed: 29343704
Mol Cell. 2007 Jan 12;25(1):151-9
pubmed: 17218278
Biomed J. 2013 May-Jun;36(3):106-17
pubmed: 23806880
Mol Cell. 2008 Dec 5;32(5):631-40
pubmed: 19061638
J Mol Biol. 2017 May 5;429(9):1406-1423
pubmed: 28363677
J Biol Chem. 2005 Feb 25;280(8):6682-91
pubmed: 15613472
J Biol Chem. 2001 Feb 2;276(5):3702-8
pubmed: 11071886
Curr Opin Struct Biol. 2004 Apr;14(2):181-8
pubmed: 15093832
Clin Cancer Res. 2007 Mar 15;13(6):1625-9
pubmed: 17363512
J Mol Biol. 2011 Aug 5;411(1):158-73
pubmed: 21658391
Biol Chem. 2019 Mar 26;400(4):487-500
pubmed: 30265648
Mol Cell. 2002 Dec;10(6):1307-18
pubmed: 12504007
Subcell Biochem. 2015;78:113-31
pubmed: 25487019
Protein Sci. 2012 Aug;21(8):1162-71
pubmed: 22653663
Nat Commun. 2014 Jun 20;5:4192
pubmed: 24947016
Front Mol Biosci. 2014 Jun 10;1:4
pubmed: 25988145

Auteurs

Wanping Xu (W)

Urologic Oncology Branch, National Cancer Institute, Bethesda, MD, 20892, USA.

Kristin Beebe (K)

Urologic Oncology Branch, National Cancer Institute, Bethesda, MD, 20892, USA.

Juan D Chavez (JD)

Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, 98195, USA.

Marta Boysen (M)

Center for Molecular Biology, University of Heidelberg, 69120, Heidelberg, Germany.

YinYing Lu (Y)

Urologic Oncology Branch, National Cancer Institute, Bethesda, MD, 20892, USA.
Center for Therapeutic Research of Hepatocarcinoma, Beijing 302 Hospital, 100 Xi Si Huan Middle Road, 100039, Beijing, China.

Abbey D Zuehlke (AD)

Urologic Oncology Branch, National Cancer Institute, Bethesda, MD, 20892, USA.

Dimitra Keramisanou (D)

Department of Chemistry, University of South Florida, Tampa, FL, 33620, USA.

Jane B Trepel (JB)

Developmental Therapeutics Branch, National Cancer Institute, Bethesda, MD, 20892, USA.

Christosomos Prodromou (C)

Genome and Damage Stability Center, University of Sussex, Brighton, BN1 9RH, UK.

Matthias P Mayer (MP)

Center for Molecular Biology, University of Heidelberg, 69120, Heidelberg, Germany.

James E Bruce (JE)

Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, 98195, USA.

Ioannis Gelis (I)

Department of Chemistry, University of South Florida, Tampa, FL, 33620, USA.

Len Neckers (L)

Urologic Oncology Branch, National Cancer Institute, Bethesda, MD, 20892, USA. neckersl@mail.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH